• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: comment by Joob and Wiwanitkit.

作者信息

Romão Vasco C, Cruz-Machado Ana Rita, Fonseca João Eurico

机构信息

Rheumatology Department, Hospital de Santa Maria, CHULN, Lisbon Academic Medical Centre, Lisbon, Portugal.

Rheumatology Research Unit, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.

出版信息

Ann Rheum Dis. 2021 Feb;80(2):e22. doi: 10.1136/annrheumdis-2020-217665. Epub 2020 May 13.

DOI:10.1136/annrheumdis-2020-217665
PMID:32404340
Abstract
摘要

相似文献

1
No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: comment by Joob and Wiwanitkit.目前尚无证据表明羟氯喹对预防新冠病毒病具有保护作用：乔布和维瓦尼特基的评论
Ann Rheum Dis. 2021 Feb;80(2):e22. doi: 10.1136/annrheumdis-2020-217665. Epub 2020 May 13.
2
Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.羟氯喹能保护风湿病患者免受新型冠状病毒肺炎（COVID-19）感染吗？对Heldwein和Calado所著的《羟氯喹能预防新型冠状病毒肺炎（COVID-19）传播吗？》以及Joob和Wiwanitkit所著的《系统性红斑狼疮、羟氯喹与非系统性红斑狼疮的新型冠状病毒肺炎（COVID-19）患者：一则评论》的回应
Ann Rheum Dis. 2020 Jun;79(6):e62. doi: 10.1136/annrheumdis-2020-217524. Epub 2020 Apr 23.
3
Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Romão and 'SLE patients are not immune to COVID-19: importance of sending the right message across' by Goyal.
Ann Rheum Dis. 2021 Feb;80(2):e24. doi: 10.1136/annrheumdis-2020-217695. Epub 2020 May 13.
4
Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.2019年冠状病毒病大流行期间系统性红斑狼疮患者的羟氯喹短缺情况：系统性红斑狼疮国际协作诊所的经验
Ann Rheum Dis. 2021 Feb;80(2):1-2. doi: 10.1136/annrheumdis-2020-218164. Epub 2020 Jun 25.
5
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.系统性红斑狼疮患者基线使用羟氯喹并不排除感染SARS-CoV-2及发生重症新型冠状病毒肺炎。
Ann Rheum Dis. 2020 Oct;79(10):1386-1388. doi: 10.1136/annrheumdis-2020-217690. Epub 2020 May 7.
6
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.COVID-19 患者伴系统性红斑狼疮，SARS-CoV-2 RNA 阳性复发后成功康复：病例报告及文献复习。
Clin Rheumatol. 2020 Sep;39(9):2803-2810. doi: 10.1007/s10067-020-05230-0. Epub 2020 Jul 28.
7
Hydroxychloroquine shortages during the COVID-19 pandemic.2019冠状病毒病大流行期间羟氯喹的短缺情况。
Ann Rheum Dis. 2021 Mar;80(3):e31. doi: 10.1136/annrheumdis-2020-217835. Epub 2020 May 20.
8
SLE patients are not immune to covid-19: importance of sending the right message across.系统性红斑狼疮患者并非对新冠病毒免疫：传递正确信息的重要性。
Ann Rheum Dis. 2021 Feb;80(2):e23. doi: 10.1136/annrheumdis-2020-217658. Epub 2020 Apr 23.
9
COVID-19 occurrence in one secukinumab-treated patient affected by hidradenitis suppurativa and systemic lupus erythematosus.一名接受司库奇尤单抗治疗、患有化脓性汗腺炎和系统性红斑狼疮的患者感染了新冠病毒。
Int J Dermatol. 2020 Nov;59(11):1423-1424. doi: 10.1111/ijd.15209. Epub 2020 Sep 23.
10
Comment on 'Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19' by Konig . Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France.对科尼格所著的《系统性红斑狼疮患者基线使用羟氯喹并不排除感染SARS-CoV-2及发生严重新型冠状病毒肺炎》的评论。长期暴露于羟氯喹或氯喹与新型冠状病毒肺炎住院风险：法国一项针对54873名暴露个体和155689名匹配的未暴露个体的全国性观察性队列研究。
Ann Rheum Dis. 2023 May;82(5):e117. doi: 10.1136/annrheumdis-2020-218647. Epub 2020 Aug 28.

引用本文的文献

1
COVID-19: A systematic review and update on prevention, diagnosis, and treatment.新型冠状病毒肺炎：预防、诊断及治疗的系统评价与更新
MedComm (2020). 2022 Feb 17;3(1):e115. doi: 10.1002/mco2.115. eCollection 2022 Mar.
2
Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis.糖皮质激素和免疫抑制疗法对慢性炎症性关节炎患者大队列中症状性 SARS-CoV-2 感染的影响。
Arthritis Res Ther. 2020 Dec 30;22(1):290. doi: 10.1186/s13075-020-02395-6.
3
Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic.
风湿性肌肉骨骼疾病与2019冠状病毒病：大流行前6个月综述
Front Med (Lausanne). 2020 Oct 9;7:562142. doi: 10.3389/fmed.2020.562142. eCollection 2020.
4
COVID-19 in a patient with a flare of systemic lupus erythematosus: A rare case-report.系统性红斑狼疮发作患者的新型冠状病毒肺炎：一例罕见病例报告。
Respir Med Case Rep. 2020;31:101252. doi: 10.1016/j.rmcr.2020.101252. Epub 2020 Oct 15.
5
COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma.新型冠状病毒肺炎与急性狼疮性肺炎：诊断与治疗困境
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620933438. doi: 10.1177/2324709620933438.